Market Research Blog

Future Market Insights (FMI), in its new report, estimates worldwide sales of walk-in coolers and freezers at US$ 8.6 billion in 2019. Widespread consumer acceptance of frozen and processed food, along with a steep rise in the demand for efficient refrigeration facilities to store and maintain the shelf life of these products, allude a brighter future for the walk-in coolers and freezers market.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-5155

According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

LACRIMAL DUCT STENT TUBE MARKET TAXONOMY

The global lacrimal duct stent tube is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

• Monocanalicular Lacrimal Duct Stent Tube
•  Bicanalicular Lacrimal Duct Stent Tube

End User

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9649

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Asia (MEA)

Increasing incidences of acute diseases like cancer has created a robust demand for effective diagnostics and treatment for the early detection of this disease and increase the probability of survival. As a result, dental X-ray systems have witnessed a rapid rise in their demand, on the back of their qualification as a promising diagnostics and treatment procedure. In addition to this, the dental X-ray systems significantly reduce the radiation dose among the patients, which strengthens the trust of the medical practitioners in the equipment and boosts the growth of the dental X-ray systems market.

Rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. According to a report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by the portable intraoral X-ray systems, the traditionally used floor mounted dental X-ray systems are gradually becoming obsolete. When weighted on the basis of cost, dental X-ray systems provides far better affordability to the dental clinics and hospitals as compared to the cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-8960

Challenges Pertaining to the Dental X-ray Systems Market: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Dental X-ray Systems Market

Innovations and advancements brought about in the medical imaging vicinity and especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of the diseases, which has been fulfilled by the dental X-ray systems. Given the multifold applications of these systems, the global dental X-ray systems market is projected to grow exponentially.

North America to Maintain a Strong Hold on the Global Dental X-ray Systems Market

The study on dental X-ray systems market provides a detailed analysis on the basis of several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to the advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8960

Collaboration and Mergers to Trigger the Growth of the Dental X-ray Systems Market

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market.

The leading players incorporated in the report are

FONA, J.

MORITA CORP.,

Danaher Corporation,

PLANMECA OY,

Prexion Corporation,

Carestream Dental,

LLC,

Owandy Radiology,

Vatech Co. Ltd.,

The Yoshida Dental Mfg. Co. Ltd.,

Dentsply Sirona,

LED Medical Diagnostics Inc.,

Cefla S.C., and Air Techniques, Inc., among others.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8960

Key Segment

Based on the product type

Cephalometric Projections Systems

Portable Intraoral X-ray Systems

Panoramic X-ray Systems

Intraoral X-ray Systems Mounted on the Floor

Based on the geographies

North America

Europe

Latin America

Middle East & Africa (MEA)

China

In a recent study, Future Market Insights (FMI) has forecast the medical nitroglycerin spray market to record consistent growth between 2020 and 2030. The report also projects the market to reach a valuation of US$147.3 Mn by the end of 2030.

Rising prevalence of cardiovascular ailments around the world have led to significant developments in cardiac treatments. Among those, heightening adoption of nitroglycerin sprays is touted as one of the most renowned treatment approaches.

Coronary heart disease is among the leading causes of morbidity and fatality amongst heart patients. This disease is the leading cause of angina pectoris, or acute chest pain, caused due to blockage of arteries. To offset the discomfort, adoption of nitroglycerin sprays is rising significantly.

A significant proportion of the global heart ailment population remain undiagnosed for angina pectoris. According to FMI, this undiagnosed population base is what would possible heighten growth prospects for the market across the upcoming forecast decade.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-12620

Key Takeaways from the Medical Nitroglycerin Sprays Study

North America touted to retain market hegemony, capturing over two-fifths of the revenue share

Prophylaxis of angina pectoris to remain the dominant segment, expanding steadily at 4.1% CAGR from 2020-2030

By distribution channel, online pharmacy sales are poised to witness credible expansion owing to the pandemic and deepening digital literacy

90 metered sprays/bottle dose capacity to remain the most preferred option, registering an index of 1.4

Global medical nitroglycerin sprays market is likely to expand steadily, registering a CAGR of 4.2%

“Continued innovations in product development to roll out effective therapeutic options for angina pectoris treatment characterize vendors’ principal expansion strategies,” concludes the FMI analyst.

COVID-19 Impact Insights

The COVID-19 pandemic has had detrimental impacts on the world at large, bringing in massive revenue shortfalls and reduced profit margins. A long-term economic recession is likely to be perpetuated for the forthcoming years.

With regard to nitroglycerin sprays, the market is expected to decelerate in the professional caregiving sector, attributed to shifting priorities towards the pandemic’s eradication. Therefore, elective surgeries for cardiac diseases are being postponed, leading to limited uptake of nitroglycerin sprays.

This deferment of elective cardiovascular surgeries is prompting patients to opt for homecare alternatives. Consequently, oral and sublingual administration of nitroglycerin sprays has been rising steadily to prevent acute angina attacks.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12620

Competitive Intelligence

The global medical nitroglycerin sprays market is highly consolidated, with the presence of four prominent players:

Perrigo Company Plc.,

Evus Health Solutions LLC., G.

Pohl-Boskamp GmbH & Co. and

Akrimax Pharmaceuticals LLC.

These players primarily concentrate on portfolio strengthening by introducing new products into the market.

For instance, in September 2020, Perrigo Company Inc. introduced the store brand equivalent of Voltaren® Arthritis Pain Reliever in over-the-counter pharmacy stores. It is the first abbreviated new drug application (ANDA) to receive U.S FDA approval.

In 2006, Evus Health Solutions received clearance from the FDA to launch the NitroMist® Nitroglycerin Lingual Aerosol Spray. The device is a nitrate vasodilator indicated for acute relief of an attack or acute prophylaxis of angina pectoris. This 400 mcg per spray is available in 230 metered or 90 metered sprays per container.

G-Pohl-Boskamp GmbH & Co. is one of Germany’s most successful independent pharmaceutical producers. Its product portfolio includes a range of products for several chronic conditions. In this case, the company manufactures the Nitrolingual Pumpspray available in 60 and 200 metered sprays per container.

More Insights on the Medical Nitroglycerin Sprays Market

Future Market Insights provides an unbiased global industry analysis (2015-2019) and opportunity assessment (2020-2030) on the medical nitroglycerin sprays market. The report provides compelling insights on basis of application (prophylaxis of angina pectoris & acute relief of attack (treatment)), dose capacity (60 metered spray/bottle, 90 metered sprays/bottle, 200 metered sprays/bottle, 230 metered sprays/bottle), and distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) across seven major regions.

Medical Nitroglycerin Sprays Market- Segmental Overview

Application

Prophylaxis of Angina Pectoris

Acute Relief of Attack (Treatment)

Dose Capacity

60 metered sprays/bottle

90 metered sprays/bottle

200 metered sprays/bottle

230 metered sprays/bottle

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12620

Region

North America (U.S & Canada)

Latin America (Brazil, Mexico, Argentina & Rest of Latin America)

Europe (Germany, Italy, France, U.K, Spain, BENELUX, Russia & Rest of Europe)

East Asia (China, Japan & South Korea)

South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)

Oceania (Australia & New Zealand)

Middle East & Africa (GCC, South Africa, Northern Africa & Rest of MEA)

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in a number of designs and utilities. According to the latest research by FMI, the global surgical booms market is expected to account for more than US$ 380 Million in terms of value by the end of 2029. The surgical booms market report also projects significant growth potential with an anticipated average Y-o-Y growth rate of over 4.5% during the forecast period.

Increase in the Adoption of Minimally Invasive Surgeries is Likely to Drive the Growth of the Surgical Booms Market

Minimally Invasive Surgery (MIS) is one of the major trends in medicine. MIS is a safe, feasible, and patient-friendly method of performing medical procedures such as surgery. MIS offers reduced postoperative pain, shorter length of stay in a hospital, lesser scarring or damage to tissues, and generally leads to faster recovery. Hence, MIS is easier and less time-consuming. As clinicians seek safer and more efficient ways to perform surgery, they find new applications for minimally invasive procedures, because the benefits of the same for patients are paramount. Furthermore, the increasing number of insurance providers that offer reimbursement for costs incurred during most minimally invasive procedures is expected to increase the adoption rate of minimally invasive surgeries. The Centers for Medicare and Medicaid Services (CMS) provides reimbursement for peripheral access procedures, such as the insertion of a port or catheter into a large central artery that is directly related to or is near the heart. Thus, increase in the number of minimally invasive surgeries is boosting the demand for equipment management systems such as equipment booms.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-4375

High Capital Investment for Integrated OR to Hinder the Growth of Surgical Booms Market

Integrated ORs utilise a crossover of medical interventions to form hybrid technologies. The development and integration of ORs requires the re-organization of professionals. In addition, there is a need to upgrade the capital equipment. Cost of such advanced capital equipment is high. Furthermore, compatibility with existing or new devices/infrastructure is likely to present a hurdle for the designers, manufacturers, and end users of surgical booms. A hybrid OR, on an average, requires 50-80% more space as compared to a conventional OR in the U.S., and 30-40% more in Germany. The additional space required is another factor that is likely to increase the cost of the setup of an integrated OR. Thus, the capital cost required for an integrated OR is likely to hinder the growth of the surgical booms market.

Surgical Booms Market: Segmental Analysis

The global surgical booms market has been segmented on the basis of product, installation, and end user. On the basis of product type, the surgical booms market has been segmented into equipment booms, utility booms, anaesthesia booms, and custom booms. Custom booms lead the market due to the flexibility of choice the customers have from manufacturers. Based on installation, the surgical booms market has been segmented into roof mounting and floor mounting. In terms of revenue, the roof mounting segment is expected to have a major share in the surgical booms market during the forecast period as these are more flexible and conserve space in the OR more effectively. On the basis of end user, the surgical booms market has been categorised into hospitals, ambulatory surgical centres, specialty clinics, and hybrid operating rooms. The revenue generated by the hospitals segment of the surgical booms market is expected to witness significant growth, which is driven by the presence of a large number of ORs and associated ICU departments at various hospitals.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-4375

Surgical Booms Market: Companies

Some of the key players in the surgical booms market include

• CV Medical LLC.
• Stryker Corporation
• Hill Rom Holdings Inc.
• Amico Group of Companies
• Steris Plc
• Ondal Medical Systems GmbH
• Getinge Group
• Pratibha Medinox
• Skytron LLc
• Palakkad Surgical Industries
• among others.

SURGICAL BOOMS MARKET TAXONOMY

By Product

• Equipment Booms
• Utility Booms
• Anesthesia Booms
• Custom Booms

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Hybrid Operating Rooms

By Installation

• Roof Mounting
• Floor Mounting

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-4375

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Afric

Robotic Spinal Surgery Market Overview

Surgical methods have transformed significantly due to the introduction of the robotic system. One such surgical method is robotic spinal surgery. Spinal surgery is a complex process due to the involvement of the delicate blood vessels and nerves, surrounding the vertebra and can cause serious problems if damaged. Usually, surgeons perform these complex surgeries by implanting the screws in the spinal bones either using their own judgment, or with the help of X-rays taken during the procedure. During this procedure, there is always a significant risk of implanting the screws in the wrong place, or in a suboptimal position. The end result could be paralysis or a less effective surgery. But with the introduction of robotic spinal surgery system surgeons can pre-plan the surgical procedure prior to the actual process and perform a more accurate surgery. The technology can customize procedures according to each patient’s individual anatomy. During the surgery, the physician has to do the real work, but robotic spinal surgery system guides the surgeon’s tools according to the predetermined method to place the implants safely and accurately in the exact pre-planned locations. Robotic spinal surgery system involves the use of robotic arms controlled by surgeons.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-3643

Robotic Spinal Surgery Market: Drivers and Restraints

Hospital cost reduction through decreased length of stay in hospital and aging of the population are the key driving factors for robotic spinal surgery market. Repeatability and reliability associated with the robotic spinal surgery are also making this method of surgery popular among physicians. Rising prevalence of chronic back pain and potential of surgical robots to increase the effectiveness of existing surgical procedures are also the growth driving factors for robotic spinal surgery market.

Robotic Spinal Surgery Market: Region Wise Outlook

Geographically, robotic spinal surgery market is segmented into, North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. North Americas region is expected to be biggest market for robotic spinal surgery mainly because of the high standards of surgical procedures and innovation by the key market players. Followed by which is Europe. Asia-Pacific region is expected to be the fastest growing market for the robotic spinal surgery attributed to increasing awareness among physicians and people regarding the treatment of spinal disorder with high accuracy and safety and increasing adoption of robots for surgical procedures by healthcare organizations.

Robotic Spinal Surgery Market: Key Market Participants

• Mazor Robotics
• Medtech SA
• Intuitive Surgical, Inc.
• Stryker
• Smith & Nephew
• NuVasive, Inc., and
• DePuy Synthes Companies.

These companies are mainly focusing on innovation and acquisition strategies.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3643

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Robotic Spinal Surgery Market: Segmentation

The global robotic spinal surgery market has been segmented on the basis of application, surgical approach, surgery type, end users, and region.

Based on application global robotic spinal surgery market can be segmented into:

• Spinal Fusion
• Laminectomy
• Disc Replacement
• Discectomy
• Foraminotomy

Based on surgical approach global robotic spinal surgery market can be segmented into:

• Anterior
• Posterior
• Lateral

Based on surgery type global robotic spinal surgery market can be segmented into:

• Open Surgery
• Minimal Invasive

Based on end users global robotic spinal surgery market can be segmented into:

• Hospitals
• Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3643

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology is increasing used in bio printing where biomaterials such as growth factors and cells are combined with bioink to create tissue-like structures that imitate natural tissues. The global 3D bioprinting market is estimated to surpass US$ 1.2 Bn by 2021, at the market CAGR of 13% during the forecast period (2020-2030), as per a new report by Future Market Insights (FMI).

3D Bioprinting Market – About the Report

[290 Pages Report] Increasing rate of medical device manufacturing across the world has been fuelling the demand for advanced technologies. 3D bioprinting is used to design medical devices. Leading medical device and pharmaceutical manufacturing companies are focusing on improving their product portfolio across the world. The demand in this market is expected to surge in response to the lack of organ donors in adequate number. With research and development (R&D) investment within the medical devices sector poised to rise significantly, the market will gain from increasing growth opportunities in the coming years.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for 3D bioprinting. The report tracks the global sales of 3D bioprinting in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and 3D bioprinting in particular. COVID-19 pandemic will show a negative impact on the 3D bioprinting market. Due to short term shut down of production facilities of medical device industries for first few months in 2020

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-808

3D bioprinting has immense potential to facilitate organ transplants and drug discovery. 3D printing can copy the actual macro and micro-environment of human organs and tissues which can solve the organ transplant crisis. Advancements in 3D printing technology and its promising applications in the healthcare industry are expected to increase the sale of 3D bioprinting over the forecast period.

As per the report, the technology will find increasing application in orthopedic implants manufacturing. The orthopedic implants segment is in fact forecast to account for over 30% of the market in terms of application.

Key Takeaways from 3D bioprinting Marker Study

• Exhibiting a little below 13% Y-o-Y growth in 2021, 3D bioprinting market will exhibit solid growth
• The U.S. will register high demand, accounting for nearly 95% of sales in North America
• Demand in U.K. is expected to rise significantly, exhibiting above 11% Y-o-Y growth in 2021
• France and Germany too will register high demand
• In East Asia, China and Japan are expected to emerge as key market

“Launch of innovative 3D printers and application of 3D bioprinting in tissue engineering and regenerative medicine, medical device manufacturing will augment the growth of global 3D bioprinting market” says the FMI Analyst

Acquisitions, Partnerships and expansion are key Strategic Focus of 3D bioprinting Market Players

Leading players in the 3D bioprinting market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

• In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation.
• In December 2019, GE Healthcare Life Sciences collaborated with Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, to build an integrated 3D bioprinter by combining their digital advanced technologies.
• In January 2020, GE Healthcare Life Sciences introduced a new additive manufacturing (AM) facility in Umeå, Sweden that will be dedicated to integrating 3D-printed parts into the company’s production of bio manufacturing equipment. With $2 million in backing, the new center is expected to increase biopharma manufacturers’ access to state-of-the-art technologies

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-808

Who is Winning?

The global market is set to expand its scope in the forecast period, due to rising prevalence of orthopedic disease globally and adoption of 3D bioprinting at various stages of development of orthopedic implants by medical manufacturers. In addition to this, cost effectiveness and increase adaption of 3D bioprinting in dental and regenerative medicine application has augmented the sales of 3D bioprinting.

The key market players covered by FMI include

• 3D Systems, Inc
• GE Healthcare (Concept Laser, Arcam AB)
• EOS GmbH Electro Optical Systems
• Renishaw plc
• Stratasys Ltd
• EnvisionTEC
• Formlabs, Inc And Organovo Holdings Inc and
• Advanced Solutions Life Sciences

consolidating their positions through mergers, acquisitions and new product launches.

3D bioprinting Market by Category

Technology

• Stereolithography (SLA)
• Selective Laser Sintering
• Electron Beam Melting
• Fused Deposition Modeling (FDM)
• Laminated Object Manufacturing (LOM
• Inkjet Printing
• Multi-phase Jet Solidification

Application

• Surgical Simulation and Training Models
• Prosthetic Devices
• Tissue Engineering and Regenerative Medicine
• Orthopedic Implants
• Dental Implants
• Medical Sensors
• Others

End User

• Medical Device Manufacturers
• Pharmaceutical Companies
• Research & Academic Institutions
• Contract Research Organizations

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-808

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Middle East and Africa (MEA)
• Oceania